Stefan Nierkens

[Café Kockelmann @CafeKockelmann]

Annelisa Cornel is betrokken bij het kweken van mini-tumoren. Waarom precies? “We kunnen hierdoor nieuwe behandelingen testen en vooraf voorspellen of die behandelingen een verschil gaan maken.” #Op1 #MAX

[Communications Medicine @CommsMedicine]

It's International #DayofImmunology! We'll be highlighting some of our recent #immunology content. First up, our recent poster on #ImmuneMonitoring in immune-mediated inflammatory disorders, by @FemkevanWijk1 @S_Nierkens & co. Edited with @NatureComms
https://t.co/s9MFCGAjfY

[Journal for ImmunoTherapy of Cancer @jitcancer]

New #JITC article: Epigenetic modulation of neuroblastoma enhances T cell and NK cell immunogenicity by inducing a tumor-cell lineage switch https://t.co/8dzdLdYZFP @S_Nierkens

[Stefan Nierkens @S_Nierkens]

New paper alert: Epigenetic modulation of neuroblastoma enhances T cell and NK cell immunogenicity by inducing a tumor-cell lineage switch | Journal for ImmunoTherapy of Cancer https://t.co/CCT27vs9za

[Infection & Immunity UMC Utrecht @IenI_UMCUtrecht]

Scientific values increasingly clash with rules, burocracy and performance indicators, resulting in young scientists to leave public research institutions. This needs to change, said @UMCUtrecht immunology professor @FemkevanWijk1 in her inaugural lecture: https://t.co/zfoxsGujuR

[Stefan Nierkens @S_Nierkens]

https://t.co/KtYLbwElGm

[Nature Portfolio @NaturePortfolio]

.@NatureComms presents a poster that explores the mechanisms underlying a number of common immune-mediated inflammatory diseases, biomarkers relevant to the diagnosis or monitoring of IMIDs, and therapies used to treat these diseases. https://t.co/jQCN5BNSmX

[Communications Medicine @CommsMedicine]

🌟 NEW POSTER! Check out our new poster on #ImmuneMonitoring & treatment in immune-mediated inflammatory diseases, created jointly with @NatureComms & authored by @FemkevanWijk1 @S_Nierkens & co @CTI_UMCUtrecht @IenI_UMCUtrecht #AutoimmuneDisease

https://t.co/s9MFCGAjfY

[PrinsesMáximaCentrum @prinsesmaximac]

We're proud of the 325 million euro National Growth Fund investment in the Oncode-PACT plan! @s_heesch: 'This investment gives a huge boost to the development of immunotherapies for cancer – in both children and adults.' https://t.co/uveTPsSdoF

[Stefan Nierkens @S_Nierkens]

https://t.co/qzJJqpPMLJ
@FrisoCalkoen @prinsesmaximac

[Sylvia Witteman @sylviawitteman]

Er zijn blijkbaar mensen, onder wie Femke Halsema, lees ik hier, die denken dat het afschaffen van gymnasia wél problemen oplost. Ongelooflijk.

Afschaffen gymnasia lost geen enkel probleem op https://t.co/dXuJm3D8ue

[Stefan Nierkens @S_Nierkens]

Fludarabine Exposure Predicts Outcome after CD19 CAR T-Cell Therapy in Children and Young Adults with Acute Leukemia https://t.co/NebP3E76se

[Frontiers - Immunology @FrontImmunol]

#HotResearchTopic🔥

📣Don't miss out!

Share your insight on “Immune recovery following hematopoietic cell transplantation”

Lead by E. Velardi, A. Toubert, S. Nierkens and M. Van Den Brink.
@velardi_Lab @AntoineToubert @S_Nierkens @DrMvandenBrink

👉https://t.co/ZJOBtholoU

[Stefan Nierkens @S_Nierkens]

Individualized dosing of anti-thymocyte globulin (ATG) improves CD4+ T cell reconstitution without increasing GVHD and graft failure incidence in pediatric unrelated HCT: results from the PARACHUTE (phase 2) trial. Towards better outcomes of allo-HCT! https://t.co/DLXc9WzJNm

[Infection & Immunity UMC Utrecht @IenI_UMCUtrecht]

HANDS UP for tumor immunologist dr. Trudy Straetemans, who will coordinate the new national platform DARE-NL that has received a grant of €5.3 M from @kwf_nl. DARE-NL aims to improve the availability of cell and gene therapy for more cancer patients https://t.co/CJpENL1U56

[New Directions in Immuno-oncology @NewDirectionsIO]

Register now for the 2nd New Directions in Immuno-oncology conference @TheCrick and online 6-8 Sept 2021 https://t.co/cOllnYaDnL

[Stefan Nierkens @S_Nierkens]

Looking for a new colleague: principal investigator Tumor Immunology

https://t.co/Mavz9Qw5Oi

[Stefan Nierkens @S_Nierkens]

Long-term effect of hematopoietic cell transplantation on systemic inflammation in patients with mucopolysaccharido… https://t.co/7S5MKRsCbl

[Cell Therapy News @celltherapynews]

New in @BMTjournal: A study led by Dr. Stefan Nierkens (@S_Nierkens) at @UMCUtrecht has found that transplantation of adolescent and adult patients with omidubicel (nicotinamide-expanded cord blood) results in full and broad immune reconstitution.

📌 https://t.co/aLYGbmzUIB